2244960-75-4

2244960-75-4 structure

2244960-75-4 structure

Name: Bepranemab
Chemical Name: Bepranemab
CAS Number: 2244960-75-4
Molecular Formula:
Molecular Weight:
Catalog: Research Areas Neurological Disease
Create Date: 2023-02-02 18:13:33
Modify Date: 2024-01-02 17:44:31
Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research[1].

Name	Bepranemab

Description	Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research[1].
Related Catalog	Research Areas >> Neurological Disease
References	[1]. Matthew E Barton, et al. Design of a patient- and investigator-blind, randomized, placebo-controlled study to evaluate efficacy, safety, and tolerability of bepranemab, UCB0107, in prodromal to mild Alzheimer’s disease: The TOGETHER Study, AH0003. Alzheimer's & Dementia. 31 December 2021.

No Any Chemical & Physical Properties